Zarzio regulatory update

Novartis’ Sandoz Inc. generics unit said FDA accepted a BLA for a biosimilar version of neutropenia drug Neupogen filgrastim G-CSF from Amgen Inc. (NASDAQ:AMGN, Thousand Oaks, Calif.). Sandoz is the...